GM says 5,000 salaried workers will take buyouts, expects $1 billion charge in first quarter

GM says 5,000 salaried workers will take buyouts, expects  billion charge in first quarter


A GMC pickup truck is displayed for sale on a lot at a General Motors dealership on January 05, 2023 in Austin, Texas.

Brandon Bell | Getty Images

DETROIT – About 5,000 white-collar workers at General Motors opted to participate in a buyout program that was announced last month to lower the automaker’s global head count and fixed costs.

GM CFO Paul Jacobson said Tuesday the company expects to take a roughly $1 billion charge during the quarter as a result of the program. The head count reduction was part of GM’s plans to cut $2 billion in structural costs by the end of 2024.

Jacobson said the opt-in rate for the “Voluntary Separation Program” was in line with company expectations, and puts GM “in a position” to avoid layoffs.

“I think we’re in a position where we’re going to be able to do that,” he said Tuesday during a BofA Securities conference.

GM expects the majority of employees who participated in the program to leave the company by the end of June, according to a spokesman.

GM CEO Mary Barra last month said if not enough employees participated in the program, involuntary actions would need to be taken.

The buyouts were offered to a majority of the company’s 58,000 U.S. white-collar employees. To qualify for the program, salaried employees needed to have worked at the company for five years as of June 30 this year. For executive-level employees, the qualification was two years worked.

“This was a tool to get us to really accelerate the attrition curve; got a pretty quick payback,” Jacobson said.

GM announced the $2 billion cost-cutting program in January, saying between 30% and 50% of the savings were expected during 2023. At the time, executives said they were planning head count reductions through attrition rather than layoffs.

Jacobson said Tuesday that GM will likely now come in on the “higher end” of that percentage range for 2023. “We feel like we’ve gotten off to a really good start on it,” he said.

GM last month said it expected to take a pretax charge of up to $1.5 billion related to the buyouts, according to a public filing. The majority of the charges are expected to be all cash and occur during the first half of the year, the company said.

GM is “working through” the full extent of the charges, Jacobson said, and may see costs spill over into the second quarter.

The company will offer additional details about the buyout program during its first-quarter earnings call on April 25, Jacobson said.

Shares of the company were down about 2% in midday trading.



Source

E.l.f. Beauty posts earnings beat, raises full-year guidance
Business

E.l.f. Beauty posts earnings beat, raises full-year guidance

Elf Beauty cosmetics Courtesy: e.l.f Beauty E.l.f. Beauty reported a huge earnings beat Wednesday and raised its guidance for the fiscal year. E.l.f. stock was up as much as 15% in after-hours trading before losing the majority of those gains. Here’s what the company reported for the third fiscal quarter, compared with analyst estimates from […]

Read More
Terrell Owens calls Hall of Fame process ‘broken’ after Belichick, Kraft snubs
Business

Terrell Owens calls Hall of Fame process ‘broken’ after Belichick, Kraft snubs

NFL Hall of Famer Terrell Owens said Wednesday that the recent snubs of New England Patriots owner Robert Kraft and former coach Bill Belichick from the institution show the system is flawed, and someone needs to be held accountable. “It’s just plain dumb” Owens told CNBC Sport in an interview in San Francisco ahead of […]

Read More
Eli Lilly’s GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026
Business

Eli Lilly’s GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026

The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters It’s a tale of two drugmakers in the red-hot obesity drug market.  Both Novo Nordisk and Eli Lilly are grappling with lower prices in the U.S., but their 2026 outlooks are diverging sharply: While Novo is bracing for a sales decline, […]

Read More